Ischemic Heart Disease in the Context of Different Comorbidities |
Autore | Costache Irina-Iuliana |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (242 p.) |
Soggetto topico |
Medicine
Cardiovascular medicine |
Soggetto non controllato |
coronary artery disease
ischemic heart disease atherosclerosis genetic risk factors heritability polymorphism GWAS PRS COVID-19 myocardial ischemia electrocardiography accelerated atherosclerosis coronary spasm coronary thrombosis endothelial dysfunction cancer prevention radiotherapy chemotherapy liver cirrhosis prevalence liver transplantation treatment myocardial injury cytokines biomarkers heart failure left ventricular remodeling myocardial infarction wall stress inflammation neurohormonal activation inflammatory bowel disease ulcerative colitis Crohn's disease cardiovascular risk frailty chronic coronary syndrome elderly acute coronary syndrome carbon monoxide poisoning severity of poisoning cardiotoxicity troponin cardiac dysfunction non-alcoholic fatty liver disease liver-heart axis |
ISBN | 3-0365-5809-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910637784603321 |
Costache Irina-Iuliana
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Pharmacogenetics to Avoid Adverse Drug Reactions |
Autore | López-Fernández Luis A |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (220 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
5-fluorouracil
capecitabine fluoropyrimidine thymidylate synthase thymidylate synthase enhancer region upstream stimulatory factor 1 adverse drug reactions pharmacogenomics epistasis random forest statin cardiovascular disease colorectal cancer personalised medicine toxicity (es)citalopram drug-gene-interaction drug-drug-interaction drug-drug-gene-interaction the PharmLines initiative antipsychotic agents pharmacogenetics cytochrome P-450 enzyme system psychotic disorders precision medicine direct oral anticoagulants clinical implementation atorvastatin SLCO1B1 HLA cutaneous adverse drug reaction SCAR genetic polymorphism antiepileptics CYP450 enzymes platelet reactivity single-nucleotide variants acute coronary syndrome clopidogrel genotype allele polymorphism HLA B CYP2C9*3 cutaneous adverse drug reactions (CADRs) anti-epileptic drugs (AEDS) phenytoin (PHT) genetic risk factors South India India cardiology adverse events guidelines |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557610103321 |
López-Fernández Luis A
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|